why choose us

First received: September 18, 2023

Clinical Trial: Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cirrhosis

Study Type: INTERVENTIONAL


Official Title: Randomized Clinical Trial in Hepatic Encephalopathy to Study Lasting Cognitive Improvement With Intravenous Albumin

Brief Summary: Hypothesis: Improvement in cognitive dysfunction with IV albumin in patients with cirrhosis with prior HE and MHE lasts for several weeks after albumin infusion has ended, and is due to persistent improvement in inflammatory markers, endothelial dysfunction, albumin function and gut microbial changes.This will be a single-arm, single-blind sequential trial of IV 25% albumin and IV saline over 8 weeks with biological sampling and cognitive and health related quality of life (HRQOL) testing with each subject acting…

Read more